Biochemistry

  1. Yeast surface display-based identification of ACE2 mutations that modulate SARS-CoV-2 spike binding across multiple mammalian species

    1. Pete Heinzelman
    2. Jonathan C. Greenhalgh
    3. Philip A. Romero

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Host PDZ-containing proteins targeted by SARS-Cov-2

    1. Célia Caillet-Saguy
    2. Fabien Durbesson
    3. Veronica V. Rezelj
    4. Gergö Gogl
    5. Quang Dinh Tran
    6. Jean-Claude Twizere
    7. Marco Vignuzzi
    8. Renaud Vincentelli
    9. Nicolas Wolff

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Identifying SARS-CoV-2 Antiviral Compounds by Screening for Small Molecule Inhibitors of nsp5 Main Protease

    1. Jennifer C Milligan
    2. Theresa U Zeisner
    3. George Papageorgiou
    4. Dhira Joshi
    5. Christelle Soudy
    6. Rachel Ulferts
    7. Mary Wu
    8. Chew Theng Lim
    9. Kang Wei Tan
    10. Florian Weissmann
    11. Berta Canal
    12. Ryo Fujisawa
    13. Tom Deegan
    14. Hema Nagara
    15. Ganka Bineva-Todd
    16. Clovis Basier
    17. Joseph F Curran
    18. Michael Howell
    19. Rupert Beale
    20. Karim Labib
    21. Nicola O’Reilly
    22. John F.X Diffley

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Bacterial expression and purification of functional recombinant SARS-CoV-2 spike receptor binding domain

    1. Janani Prahlad
    2. Lucas R. Struble
    3. William E. Lutz
    4. Savanna A. Wallin
    5. Surender Khurana
    6. Andy Schnaubelt
    7. Mara J. Broadhurst
    8. Kenneth W. Bayles
    9. Gloria E. O. Borgstahl

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Identifying SARS-CoV-2 Antiviral Compounds by Screening for Small Molecule Inhibitors of Nsp14/nsp10 Exoribonuclease

    1. Berta Canal
    2. Allison W. McClure
    3. Joseph F. Curran
    4. Mary Wu
    5. Rachel Ulferts
    6. Florian Weissmann
    7. Jingkun Zeng
    8. Agustina P. Bertolin
    9. Jennifer C. Milligan
    10. Souradeep Basu
    11. Lucy S. Drury
    12. Tom Deegan
    13. Ryo Fujisawa
    14. Emma L. Roberts
    15. Clovis Basier
    16. Karim Labib
    17. Rupert Beale
    18. Michael Howell
    19. John F.X Diffley

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Characterization of protease activity of Nsp3 from SARS-CoV-2 and its in vitro inhibition by nanobodies

    1. Lee A. Armstrong
    2. Sven M. Lange
    3. Virginia de Cesare
    4. Stephen P. Matthews
    5. Raja Sekar Nirujogi
    6. Isobel Cole
    7. Anthony Hope
    8. Fraser Cunningham
    9. Rachel Toth
    10. Rukmini Mukherjee
    11. Denisa Bojkova
    12. Franz Gruber
    13. David Gray
    14. Paul G. Wyatt
    15. Jindrich Cinatl
    16. Ivan Dikic
    17. Paul Davies
    18. Yogesh Kulathu

    Reviewed by ScreenIT

    2 evaluationsAppears in 1 listLatest version Latest activity

  7. Interactions of SARS-CoV-2 envelope protein with amilorides correlate with antiviral activity

    1. Sang Ho Park
    2. Haley Siddiqi
    3. Daniela V. Castro
    4. Anna De Angelis
    5. Aaron L. Oom
    6. Charlotte A. Stoneham
    7. Mary K. Lewinski
    8. Alex E. Clark
    9. Ben A. Croker
    10. Aaron F. Carlin
    11. John Guatelli
    12. Stanley J. Opella

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Structural and functional characterization of SARS-CoV-2 RBD domains produced in mammalian cells

    1. Christoph Gstöttner
    2. Tao Zhang
    3. Anja Resemann
    4. Sophia Ruben
    5. Stuart Pengelley
    6. Detlev Suckau
    7. Tim Welsink
    8. Manfred Wuhrer
    9. Elena Domínguez-Vega

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Serological Profile Of Specific Antibodies Against Dominant Antigens Of SARS-CoV-2 In Chilean COVID-19 Patients.

    1. K. Cereceda
    2. R. González-Stegmaier
    3. JL. Briones
    4. C. Selman
    5. A. Aguirre
    6. G. Valenzuela-Nieto
    7. C. Caglevic
    8. R. Gazitua
    9. A. Rojas-Fernandez
    10. F. Villarroel-Espíndola

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. 501Y.V2 and 501Y.V3 variants of SARS-CoV-2 lose binding to Bamlanivimab in vitro

    1. Haolin Liu
    2. Pengcheng Wei
    3. Qianqian Zhang
    4. Zhongzhou Chen
    5. Katja Aviszus
    6. Walter Downing
    7. Shelley Peterson
    8. Lyndon Reynoso
    9. Gregory P. Downey
    10. Stephen K. Frankel
    11. John Kappler
    12. Philippa Marrack
    13. Gongyi Zhang

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 84 of 93 Next